NCT Number: NCT02218788
The purpose of this study is to assess the safety and performance of Hydroxytite in all subjects who have received sub dermal or deep dermal injections.
Looking for future studies?
Notify MeHealthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 6 months
Adverse events or Serious adverse events, Injection site reactions.
Time frame: 6 months
To give a score, using the LRS, to Hydroxytite treatment compared to patient's baseline
Time frame: 6 months
To give a score, using the Global Aesthetic Improvement Scale (GAIS), to Hydroxytite treatment compared to patient's baseline
Looking for future studies?
Notify MePanaxia Ltd
Industry
An Open-label, Retrospective, Postmarketing Study of Safety and Performance of Hydroxytite, a Calcium Hydroxyapatite Based Filler for Facial Soft Tissue Augmentation.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07736703
Folds, Wrinkles
Lod, Israel
View Trial DetailsNCT07111156
Facial Sign of Aging, Fine Lines
Ahmedabad, Gujarat, India
View Trial DetailsNCT01529983
Wrinkles
Chicago, Illinois, United States
View Trial DetailsNCT06724510
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases
Beijing, China
View Trial Details